Epigral Profile
Key Indicators
- Authorised Capital ₹ 573.13 Cr
as on 03-12-2024
- Paid Up Capital ₹ 43.14 Cr
as on 03-12-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2,514.75 Cr
as on 03-12-2024
- Satisfied Charges ₹ 1,380.50 Cr
as on 03-12-2024
About Epigral
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543332 and on the National Stock Exchange(NSE) under MFL.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 573.13 Cr and a paid-up capital of Rs 43.14 Cr.
The company currently has active open charges totaling ₹2,514.75 Cr. The company has closed loans amounting to ₹1,380.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Epigral Limited India are Sanjay Jain as Cfo, Gaurang Trivedi as Company Secretary, and Kaushal Soparkar as Ceo. Sanjay Asher, Kanubhai Patel, Manubhai Patel, and Seven other members serve as directors at the Company.
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Epigral Limited offer?
Epigral Limited offers a wide range of products and services, including Insecticides, Biopesticides, Bleaching Powder, Hydrogen Peroxide.
Who are the key members and board of directors at Epigral?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maulik Patel  | Managing Director | 10-May-2016 | Current |
| Sanjay Jain | CFO | 07-May-2014 | Current |
| Gaurang Trivedi | Company Secretary | 20-May-2024 | Current |
| Kaushal Soparkar | CEO | 01-Apr-2017 | Current |
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Asher | Director | 20-May-2021 | Current |
| Raju Swamy | Director | 20-May-2021 | Current |
| Nirali Parikh | Director | 30-Mar-2015 | Current |
| Kanubhai Patel | Director | 20-May-2021 | Current |
| Manubhai Patel | Director | 18-May-2017 | Current |
| Karana Patel | Director | 10-May-2016 | Current |
Financial Performance of Epigral.
Epigral Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Epigral?
In 2024, Epigral had a promoter holding of 71.49% and a public holding of 28.50%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Meghmani FoundationActive 2 years 1 monthKarana Patel, Kaushal Soparkar and 3 more are mutual person
Matangi Industries Limited Liability Par TnershipActive 10 years 1 monthAnkit Patel is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 12 Jun 2024 | ₹350.00 Cr | Open |
Axis Bank Limited Creation Date: 22 Apr 2024 | ₹350.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Jun 2021 | ₹284.75 Cr | Open |
How Many Employees Work at Epigral?
Epigral has a workforce of 967 employees as of Dec 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Epigral, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epigral's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
